SPAGO.ST实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 22:42):

Stats
今日成交量	615 527
平均成交量	139 503
市值	80.90M
EPS	SEK-0.0747 ( 2023-11-03 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.900
ATR14	SEK0.00600 (1.67%)

音量相关性

長: -0.11 (neutral)

短: -0.59 (weak negative)

Signal:(53.663) Neutral

Spago Nanomedical AB 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Spago Nanomedical AB 相关性 - 货币/商品

-0.49
( neutral )

-0.65
( moderate negative )

0.00
( neutral )

-0.49
( neutral )

Spago Nanomedical AB 财务报表

Annual	2023
营收:	SEK1.20M
毛利润:	SEK-22.75M (-1 890.86 %)
EPS:	SEK-0.430

FY	2023
营收:	SEK1.20M
毛利润:	SEK-22.75M (-1 890.86 %)
EPS:	SEK-0.430

FY	2022
营收:	SEK1.05M
毛利润:	SEK-15.60M (-1 480.46 %)
EPS:	SEK-0.590

FY	2021
营收:	SEK660 000
毛利润:	SEK-16.78M (-2 541.82 %)
EPS:	SEK-1.430

Financial Reports:

No articles found.

Spago Nanomedical AB

Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.